Breaking News Instant updates and real-time market news.

NVS

Novartis

$73.38

-0.24 (-0.33%)

13:50
04/21/17
04/21
13:50
04/21/17
13:50

Novartis plans to launch three more biosimilars by 2020

Sandoz, a Novartis division, announced that the EMA's Committee for Medicinal Products for Human Use has adopted positive opinions, separately recommending the approval of both Sandoz' biosimilar rituximab and biosimilar etanercept in Europe, to treat the same indications as their respective reference medicines. The company added: "Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. It is the pioneer and global leader in biosimilars, and currently markets three biosimilars worldwide. Sandoz has a leading biosimilar pipeline and, in addition to biosimilar rituximab and etanercept, plans to launch three more biosimilars of major oncology and immunology biologics across key geographies by 2020."

  • 03

    May

  • 06

    Jun

  • 26

    Jun

NVS Novartis
$73.38

-0.24 (-0.33%)

04/05/17
COWN
04/05/17
DOWNGRADE
Target $77
COWN
Market Perform
Novartis downgraded to Market Perform from Outperform at Cowen
Cowen analyst Steve Scala downgraded Novartis to Market Perform and lowered his price target for the shares to $77 from $87. The analyst believes the company's earnings growth looks below the industry average given the current weakness in Alcon and Entresto's slow rollout.
04/05/17
04/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Neutral from Buy at UBS. 2. Novartis (NVS) downgraded to Market Perform from Outperform at Cowen with analyst Steve Scala saying he believes the company's earnings growth looks below the industry average given the current weakness in Alcon and Entresto's slow rollout. 3. MSG Networks (MSGN) downgraded to Neutral following NY Post report at Macquarie with analyst Tim Nollen citing valuation and maintained its $26 price target. 4. Generac (GNRC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jeffrey Hammond citing concerns that increased pricing incentives and normalizing storm activity are impacting the growth for the company's Residential home standby business. 5. Amgen (AMGN) downgraded to Hold from Buy at Jefferies with analyst Eun Yang saying she believes upside in the stock will likely be "muted" after her payor poll indicated continuing reimbursement challenges for Repatha, Amgen's PCSK9 inhibitor to treat high cholesterol. Yang also sees a "scarcity of blockbuster potential pipeline products" and feels a transformative acquisition is unlikely. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/17
WELS
04/18/17
NO CHANGE
WELS
Allergan partnership a 'promising free option,' says Wells Fargo
Wells Fargo analyst David Maris views Allergan's (AGN) partnership with Novartis (NVS) to conduct a Phase IIb study using its cenicriviroc and Novartis's lead FXR agonist for the treatment of nonalcoholic steatohepatitis as a "promising free option." The deal is a way to maximize Allergan's shots-on-goal in combination NASH treatments, Maris tells investors in a research note. He has an Outperform rating on Allergan shares.
04/21/17
ROTH
04/21/17
NO CHANGE
Target $12
ROTH
Buy
Conatus price target raised to $12 from $4 at Roth Capital
Roth Capital analyst Sa'ar Yaniv raised his price target for Conatus (CNAT) to $12 from $4 following discussions with management, 2016 results, assessment of the competitive cirrhosis space, and clarity from the Novartis (NVS) deal. The analyst believes Conatus' shares are undervalued and reiterates a Buy rating on the stock.

TODAY'S FREE FLY STORIES

JNJ

Johnson & Johnson

$146.98

0.12 (0.08%)

17:05
01/17/18
01/17
17:05
01/17/18
17:05
Hot Stocks
Johnson & Johnson issues statement on ZYTIGA Inter Partes reviews »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

EVEP

EV Energy

$0.89

0.015 (1.71%)

17:03
01/17/18
01/17
17:03
01/17/18
17:03
Hot Stocks
EV Energy announces extension of grace period to meet NASDAQ requirement »

EV Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$10.05

0.1 (1.01%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Hudbay Minerals sees FY18 CapEx $245M »

Hudbay Minerals released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFE

Safeguard Scientifics

$10.85

-0.15 (-1.36%)

17:02
01/17/18
01/17
17:02
01/17/18
17:02
Hot Stocks
Safeguard Scientifics to implement changes in business strategy and operations »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

, SSTI

ShotSpotter

$16.10

0.06 (0.37%)

16:55
01/17/18
01/17
16:55
01/17/18
16:55
Hot Stocks
Motorola Solutions reports 9.8% passive stake in ShotSpotter »

In a regulatory filing,…

MSI

Motorola Solutions

$97.28

1.42 (1.48%)

SSTI

ShotSpotter

$16.10

0.06 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ERIE

Erie Indemnity

$117.23

1.44 (1.24%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Hot Stocks
Erie Indemnity sees $20M in tax expense as a result of new tax law »

Erie Indemnity expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.10

2.91 (1.65%)

16:52
01/17/18
01/17
16:52
01/17/18
16:52
Periodicals
Apple to issue $2,500 restricted stock bonuses to workers, Bloomberg says »

Apple informed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SLM

Sallie Mae

$11.49

0.02 (0.17%)

16:51
01/17/18
01/17
16:51
01/17/18
16:51
Earnings
Sallie Mae reports Q4 core EPS 19c, consensus 19c »

Reports Q4 GAAP net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

16:45
01/17/18
01/17
16:45
01/17/18
16:45
General news
Treasury TIC flows: foreign accounts bought $33.8 B in total U.S. assets »

Treasury TIC flows:…

VZ

Verizon

$51.72

0.06 (0.12%)

16:43
01/17/18
01/17
16:43
01/17/18
16:43
Hot Stocks
Verizon to record cumulative adjustment to retained earnings during 1Q18 »

Verizon said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VZ

Verizon

$51.72

0.06 (0.12%)

16:42
01/17/18
01/17
16:42
01/17/18
16:42
Hot Stocks
Verizon sees $4.10 impact to FY17 EPS after tax reform »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BELFA

Bel Fuse

, BELFB

Bel Fuse

$24.70

0.25 (1.02%)

16:39
01/17/18
01/17
16:39
01/17/18
16:39
Earnings
Bel Fuse anticipates Q4 revenue $120M, 1 estimate $124M »

The company's…

BELFA

Bel Fuse

BELFB

Bel Fuse

$24.70

0.25 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:37
01/17/18
01/17
16:37
01/17/18
16:37
General news
API crude inventories for week of January 12 »

API reports that crude…

SLM

Sallie Mae

$11.49

0.02 (0.17%)

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Earnings
Sallie Mae sees initial FY18 EPS 97c-$1.01, consensus $1.04 »

Sees FY18 private…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Hot Stocks
Antero Midstream GP provides distribution guidance for 2018 through 2022 »

Antero Midstream GP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:36
01/17/18
01/17
16:36
01/17/18
16:36
Hot Stocks
Antero Resources sees FY18 CapEx $1.45B »

Antero's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:35
01/17/18
01/17
16:35
01/17/18
16:35
Hot Stocks
Antero Resources sees Q4 net daily gas equivalent production 2,347 MMcfe/d »

Preliminary Fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

HBHC

Hancock Holding

$54.45

0.9 (1.68%)

16:35
01/17/18
01/17
16:35
01/17/18
16:35
Earnings
Hancock Holding reports Q4 EPS with items 64c, consensus 83c »

The fourth quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AR

Antero Resources

16:34
01/17/18
01/17
16:34
01/17/18
16:34
Hot Stocks
Antero Resources sees net daily production approximately 2.7 Bcfe/d in 2018 »

2018 Guidance and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

16:33
01/17/18
01/17
16:33
01/17/18
16:33
Hot Stocks
Antero Midstream Partners provides 2018 and long-term target guidance »

Antero Midstream provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

SBOW

SilverBow Resources

$31.48

0.52 (1.68%)

16:32
01/17/18
01/17
16:32
01/17/18
16:32
Hot Stocks
SilverBow Resources sees 2018 capital program of $245M-$265M »

SilverBow Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

RDN

Radian Group

$22.26

0.13 (0.59%)

16:31
01/17/18
01/17
16:31
01/17/18
16:31
Hot Stocks
Radian Group updates on capital actions »

Radian Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$54.02

0.48 (0.90%)

16:30
01/17/18
01/17
16:30
01/17/18
16:30
Initiation
Hess Corp. initiated  »

Hess Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

16:30
01/17/18
01/17
16:30
01/17/18
16:30
Options
Preliminary option volume of 23.6M today »

Preliminary option volume…

AAPL

Apple

$179.10

2.91 (1.65%)

, JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

16:25
01/17/18
01/17
16:25
01/17/18
16:25
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened higher and…

AAPL

Apple

$179.10

2.91 (1.65%)

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

CELG

Celgene

$102.02

-2.8 (-2.67%)

BLUE

bluebird bio

$175.25

11.9 (7.29%)

BLCM

Bellicum Pharmaceuticals

$8.45

-0.01 (-0.12%)

CLLS

Cellectis

$30.19

2.41 (8.68%)

BAC

Bank of America

$31.18

-0.06 (-0.19%)

GS

Goldman Sachs

$253.65

-4.81 (-1.86%)

BA

Boeing

$351.01

15.85 (4.73%)

ERJ

Embraer

$24.69

-0.09 (-0.36%)

GT

Goodyear Tire

$34.37

0.87 (2.60%)

PSTG

Pure Storage

$17.89

1.73 (10.71%)

F

Ford

$12.18

-0.92 (-7.02%)

FAST

Fastenal

$52.20

-3.24 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 26

    Feb

  • 14

    Mar

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.